$1
+0.02
(+2.04%)▲
Revenue is down for the last 5 quarters, 52.76M → 24.16M (in $), with an average decrease of 17.2% per quarter
Netprofit is up for the last 5 quarters, -710.88M → 722.0K (in $), with an average increase of 2101.2% per quarter
In the last 1 year, Zoetis Inc - Class A has given 1.7% return, outperforming this stock by 73.3%
In the last 3 years, Zoetis Inc - Class A has given 22.3% return, outperforming this stock by 119.9%
0.99%
Downside
Day's Volatility :4.46%
Upside
3.5%
9.94%
Downside
52 Weeks Volatility :77.43%
Upside
74.94%
Period | Hexo Corp | Russel 2000 | Index (Russel 2000) |
---|---|---|---|
3 Months | -38.27% | -8.3% | -8.3% |
6 Months | -60.25% | -6.5% | -6.5% |
1 Year | -71.71% | -6.1% | -6.1% |
3 Years | -97.55% | 21.8% | 21.8% |
Market Capitalization | 43.1M |
Book Value | $5.88 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -1.65 |
Wall Street Target Price | 1.26 |
Profit Margin | -203.25% |
Operating Margin TTM | -115.33% |
Return On Assets TTM | -14.22% |
Return On Equity TTM | -83.49% |
Revenue TTM | 148.1M |
Revenue Per Share TTM | 3.86 |
Quarterly Revenue Growth YOY | -54.2% |
Gross Profit TTM | -75.7M |
EBITDA | -142.7M |
Diluted Eps TTM | -1.65 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.32 |
EPS Estimate Next Year | -0.51 |
EPS Estimate Current Quarter | -0.16 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 26.0%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 4.1M | - |
Net Income | -12.4M | ↑ 15808.34% |
Net Profit Margin | -303.1% | - |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 4.9M | ↑ 20.43% |
Net Income | -23.3M | ↑ 88.04% |
Net Profit Margin | -473.25% | ↓ 170.15% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 47.5M | ↑ 863.55% |
Net Income | -81.6M | ↑ 249.31% |
Net Profit Margin | -171.57% | ↑ 301.68% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 80.8M | ↑ 69.92% |
Net Income | -546.5M | ↑ 570.01% |
Net Profit Margin | -676.48% | ↓ 504.91% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 123.8M | ↑ 53.21% |
Net Income | -114.8M | ↓ 79.0% |
Net Profit Margin | -92.72% | ↑ 583.76% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 149.3M | ↑ 54.4% |
Net Income | -838.9M | ↑ 835.51% |
Net Profit Margin | -561.8% | ↓ 469.08% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Revenue | 40.5M | ↑ 29.48% |
Net Income | -94.7M | ↑ 69.92% |
Net Profit Margin | -233.67% | ↓ 55.62% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 41.4M | ↑ 5.13% |
Net Income | -557.2M | ↑ 506.19% |
Net Profit Margin | -1.3K% | ↓ 1113.65% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 35.4M | ↓ 13.63% |
Net Income | -112.8M | ↓ 79.6% |
Net Profit Margin | -318.21% | ↑ 1029.11% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 33.3M | ↓ 6.55% |
Net Income | -78.5M | ↓ 30.73% |
Net Profit Margin | -235.86% | ↑ 82.35% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 26.3M | ↓ 16.0% |
Net Income | -41.3M | ↓ 43.99% |
Net Profit Margin | -157.26% | ↑ 78.6% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 18.1M | ↓ 32.46% |
Net Income | 539.5K | ↓ 101.28% |
Net Profit Margin | 2.99% | ↑ 160.25% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 56.2M | ↑ 6820.5% |
Total Liabilities | 23.7M | ↑ 205293.96% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 335.0M | ↑ 496.3% |
Total Liabilities | 12.1M | ↓ 48.93% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 881.0M | ↑ 163.0% |
Total Liabilities | 104.3M | ↑ 760.11% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 693.0M | ↓ 21.35% |
Total Liabilities | 136.2M | ↑ 30.6% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.3B | ↑ 89.3% |
Total Liabilities | 579.5M | ↑ 325.53% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 532.1M | ↓ 48.09% |
Total Liabilities | 287.0M | ↓ 36.63% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Total Assets | 1.3B | ↑ 23.04% |
Total Liabilities | 444.2M | ↓ 5.13% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 763.4M | ↓ 39.65% |
Total Liabilities | 398.2M | ↓ 7.59% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 660.3M | ↓ 12.83% |
Total Liabilities | 371.9M | ↓ 5.89% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 532.1M | ↓ 19.79% |
Total Liabilities | 287.0M | ↓ 23.19% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 453.4M | ↓ 9.4% |
Total Liabilities | 259.5M | ↓ 3.85% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 394.3M | ↓ 14.45% |
Total Liabilities | 203.7M | ↓ 22.78% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -5.3M | ↑ 4591.41% |
Investing Cash Flow | -6.3M | - |
Financing Cash Flow | 48.2M | - |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -22.2M | ↑ 317.71% |
Investing Cash Flow | -200.4M | ↑ 3060.93% |
Financing Cash Flow | 283.2M | ↑ 487.8% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -128.4M | ↑ 478.94% |
Investing Cash Flow | -7.6M | ↓ 96.18% |
Financing Cash Flow | 150.6M | ↓ 46.81% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -94.6M | ↓ 26.38% |
Investing Cash Flow | -83.0M | ↑ 986.25% |
Financing Cash Flow | 248.2M | ↑ 64.8% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -43.1M | ↓ 54.45% |
Investing Cash Flow | -451.6M | ↑ 443.83% |
Financing Cash Flow | 378.0M | ↑ 52.28% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -91.2M | ↑ 170.93% |
Investing Cash Flow | -12.8M | ↓ 96.39% |
Financing Cash Flow | 116.3M | ↓ 60.64% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -45.6M | ↑ 115.39% |
Investing Cash Flow | -96.1M | ↓ 69.91% |
Financing Cash Flow | 132.3M | ↓ 59.86% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -27.6M | ↓ 37.61% |
Investing Cash Flow | 6.1M | ↓ 106.55% |
Financing Cash Flow | 7.4M | ↓ 94.25% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -7.3M | ↓ 73.49% |
Investing Cash Flow | -10.7M | ↓ 276.19% |
Financing Cash Flow | -332.1K | ↓ 104.53% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -12.2M | ↑ 66.84% |
Investing Cash Flow | 84.9M | ↓ 891.04% |
Financing Cash Flow | -18.8M | ↑ 5524.12% |
Sell
Neutral
Buy
Hexo Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Hexo Corp | -23.66% | -60.25% | -71.71% | -97.55% | -99.66% |
![]() Neurocrine Biosciences Inc. | -3.67% | -25.55% | -1.95% | -23.14% | -8.16% |
![]() Zoetis Inc. | -3.69% | 10.65% | 0.51% | 22.32% | 101.29% |
![]() Viatris Inc. | 3.44% | -14.56% | -20.73% | -42.9% | -42.9% |
![]() Catalent, Inc. | -23.38% | -25.7% | -66.09% | -50.96% | -4.0% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Hexo Corp | NA | NA | NA | -0.32 | -0.83 | -0.14 | 0.0 | 5.88 |
![]() Neurocrine Biosciences Inc. | 144.75 | 144.75 | 1.87 | 2.1 | 0.04 | 0.08 | 0.0 | 17.28 |
![]() Zoetis Inc. | 36.8 | 36.8 | 3.53 | 5.4 | 0.45 | 0.13 | 0.01 | 9.72 |
![]() Viatris Inc. | 5.88 | 5.88 | NA | 2.95 | 0.09 | 0.03 | 0.05 | 17.45 |
![]() Catalent, Inc. | 16.06 | 16.06 | 1.18 | 1.37 | 0.09 | 0.04 | 0.0 | 27.29 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Hexo Corp | Sell | $43.1M | -99.66% | NA | -203.25% |
![]() Neurocrine Biosciences Inc. | Buy | $8.9B | -8.16% | 144.75 | 4.0% |
![]() Zoetis Inc. | Buy | $75.3B | 101.29% | 36.8 | 25.59% |
![]() Viatris Inc. | Hold | $11.1B | -42.9% | 5.88 | 12.05% |
![]() Catalent, Inc. | Buy | $6.7B | -4.0% | 16.06 | 8.62% |
Mirae Asset Global Investments (Korea) Co Ltd
Renaissance Technologies Corp
Millennium Management LLC
Scotia Capital Inc
Susquehanna International Group, LLP
JANE STREET GROUP, LLC
Hexo Corp’s price-to-earnings ratio stands at None
Read MoreHEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis.
Organization | Hexo Corp |
Employees | 0 |
CEO | Mr. Mark Attanasio |
Industry | Pharmaceuticals: Other |
Marathon Digital Holdings Inc
$10.03
+0.4%
MARBLEGATE ACQUISITION CORP.
$10.18
+0.0%
BLACK MOUNTAIN ACQUISITION-A
$10.55
+0.0%
BLOCKCHAIN COINVESTORS ACQUISITION CORP.
$10.51
+0.29%
IQ CHAIKIN US LARGE CAP ETF
$31.64
-0.03%
LARGO RESOURCES LTD
$3.82
+0.53%
LUTHER BURBANK CORP
$9.39
+6.58%
Standard Motor Products Inc
$37.12
+3.66%
Anfield Capital Diversified Alternatives ETF
$8.36
+1.7%